| IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours MF Amary, K Bacsi, F Maggiani, S Damato, D Halai, F Berisha, R Pollock, ... The Journal of pathology 224 (3), 334-343, 2011 | 1049 | 2011 |
| Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2 MF Amary, S Damato, D Halai, M Eskandarpour, F Berisha, F Bonar, ... Nature genetics 43 (12), 1262-1265, 2011 | 456 | 2011 |
| Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2 P Guilhamon, M Eskandarpour, D Halai, GA Wilson, A Feber, ... Nature communications 4 (1), 2166, 2013 | 180 | 2013 |
| Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells M Eskandarpour, S Kiaii, C Zhu, J Castro, AJ Sakko, J Hansson International journal of cancer 115 (1), 65-73, 2005 | 115 | 2005 |
| Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium AJ Siddiqui, P Blomberg, E Wärdell, I Hellgren, M Eskandarpour, KB Islam, ... Biochemical and biophysical research communications 310 (3), 1002-1009, 2003 | 113 | 2003 |
| Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations M Eskandarpour, J Hashemi, L Kanter, U Ringborg, A Platz, J Hansson Journal of the National Cancer Institute 95 (11), 790-798, 2003 | 108 | 2003 |
| Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B C Berking, R Takemoto, K Satyamoorthy, T Shirakawa, M Eskandarpour, ... Cancer research 64 (3), 807-811, 2004 | 102 | 2004 |
| Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro M Eskandarpour, F Huang, KA Reeves, E Clark, J Hansson International journal of cancer 124 (1), 16-26, 2009 | 82 | 2009 |
| MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression N Presneau, M Eskandarpour, T Shemais, S Henderson, D Halai, ... British journal of cancer 108 (4), 964-972, 2013 | 80 | 2013 |
| T-bet activates Th1 genes through mediator and the super elongation complex A Hertweck, CM Evans, M Eskandarpour, JCH Lau, K Oleinika, I Jackson, ... Cell reports 15 (12), 2756-2770, 2016 | 70 | 2016 |
| Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations B Jovanovic, S Egyhazi, M Eskandarpour, P Ghiorzo, JM Palmer, ... The Journal of investigative dermatology 130 (2), 618, 2010 | 47 | 2010 |
| Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle P Blomberg, M Eskandarpour, S Xia, C Sylvén, KB Islam Biochemical and biophysical research communications 298 (4), 505-510, 2002 | 43 | 2002 |
| Pharmacological inhibition of bromodomain proteins suppresses retinal inflammatory disease and downregulates retinal Th17 cells M Eskandarpour, R Alexander, P Adamson, VL Calder The Journal of Immunology 198 (3), 1093-1103, 2017 | 30 | 2017 |
| Nonsurgical direct delivery of plasmid DNA into rat heart: time course, dose response, and the influence of different promoters on gene expression N Sarkar, P Blomberg, E Wärdell, M Eskandarpour, C Sylvén, V Drvota, ... Journal of cardiovascular pharmacology 39 (2), 215-224, 2002 | 25 | 2002 |
| Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas N Presneau, LA Duhamel, H Ye, R Tirabosco, AM Flanagan, ... British Journal of Cancer 117 (3), 398-408, 2017 | 16 | 2017 |
| Adhesion molecule targeted therapy for non-infectious uveitis YH Chen, S Lightman, M Eskandarpour, VL Calder International Journal of Molecular Sciences 23 (1), 503, 2022 | 13 | 2022 |
| Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis YH Chen, M Eskandarpour, X Zhang, G Galatowicz, J Greenwood, ... Journal of Neuroinflammation 18, 1-13, 2021 | 13 | 2021 |
| The topical ocular delivery of rapamycin to posterior eye tissues and the suppression of retinal inflammatory disease MY Badr, AA Halwani, U Odunze, M Eskandarpour, VL Calder, ... International Journal of Pharmaceutics 621, 121755, 2022 | 12 | 2022 |
| Functionally distinct IFN‐γ+IL‐17A+ Th cells in experimental autoimmune uveitis: T‐cell heterogeneity, migration, and steroid response YH Chen, M Eskandarpour, A Gondrand, X Zhang, R Gu, G Galatowicz, ... European Journal of Immunology 50 (12), 1941-1951, 2020 | 10 | 2020 |
| Immune-mediated retinal vasculitis in posterior uveitis and experimental models: the leukotriene (LT) B4-VEGF axis M Eskandarpour, MA Nunn, W Weston-Davies, VL Calder Cells 10 (2), 396, 2021 | 9 | 2021 |
